American Healthcare REIT (NYSE:AHR) Given a $45.00 Price Target at Royal Bank Of Canada

Key Points

• Royal Bank of Canada has raised its target price for American Healthcare REIT stock from $39.00 to $45.00, indicating a potential upside of 11.80% from the previous close.
• Multiple analysts, including Morgan Stanley and JMP Securities, have also set their price targets for American Healthcare REIT at $45.00, with several ratings upgraded to "outperform" or "strong-buy."
• American Healthcare REIT reported a quarterly EPS of $0.42, exceeding expectations and showing a 7.5% year-over-year revenue increase, with revenue at $542.50 million compared to estimates of $539.49 million.

American Healthcare REIT (NYSE:AHR - Get Free Report) has been assigned a $45.00 target price by analysts at Royal Bank Of Canada in a research report issued on Wednesday, MarketBeat Ratings reports. The brokerage presently has an "outperform" rating on the stock. Royal Bank Of Canada's price target would indicate a potential upside of 11.25% from the company's current price.

Several other analysts have also recently commented on AHR. KeyCorp raised their target price on shares of American Healthcare REIT from $34.00 to $40.00 and gave the stock an "overweight" rating in a research note on Wednesday, June 11th. Truist Financial raised their target price on shares of American Healthcare REIT from $32.00 to $38.00 and gave the stock a "buy" rating in a research note on Monday, June 9th. Scotiabank started coverage on shares of American Healthcare REIT in a research note on Monday, June 30th. They issued a "sector outperform" rating and a $42.00 target price for the company. JMP Securities raised their target price on shares of American Healthcare REIT from $40.00 to $45.00 and gave the stock a "market outperform" rating in a research note on Monday, August 11th. Finally, Morgan Stanley raised their target price on shares of American Healthcare REIT from $37.00 to $45.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 20th. Ten investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Buy" and an average target price of $40.44.

American Healthcare REIT Stock Up 0.1%

Shares of NYSE AHR traded up $0.06 during mid-day trading on Wednesday, reaching $40.45. The company had a trading volume of 1,592,997 shares, compared to its average volume of 1,319,109. The company has a current ratio of 0.48, a quick ratio of 0.38 and a debt-to-equity ratio of 0.41. The firm has a 50 day simple moving average of $37.43 and a two-hundred day simple moving average of $33.10. The stock has a market cap of $6.82 billion, a P/E ratio of -183.86, a PEG ratio of 2.24 and a beta of 1.08. American Healthcare REIT has a 52-week low of $18.49 and a 52-week high of $41.50.

American Healthcare REIT (NYSE:AHR - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.42 earnings per share for the quarter, topping analysts' consensus estimates of $0.40 by $0.02. The firm had revenue of $542.50 million during the quarter, compared to analysts' expectations of $539.49 million. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. American Healthcare REIT's quarterly revenue was up 7.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.33 EPS. Sell-side analysts predict that American Healthcare REIT will post 1.41 earnings per share for the current year.

Insider Activity at American Healthcare REIT

In related news, CIO Stefan K.L. Oh sold 3,860 shares of the firm's stock in a transaction dated Monday, June 30th. The shares were sold at an average price of $36.10, for a total value of $139,346.00. Following the completion of the sale, the executive owned 95,671 shares in the company, valued at $3,453,723.10. This trade represents a 3.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.92% of the stock is owned by company insiders.

Institutional Trading of American Healthcare REIT

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. increased its holdings in American Healthcare REIT by 22.4% during the 1st quarter. Vanguard Group Inc. now owns 18,795,192 shares of the company's stock valued at $569,494,000 after acquiring an additional 3,437,861 shares in the last quarter. Principal Financial Group Inc. increased its holdings in American Healthcare REIT by 1.1% during the 1st quarter. Principal Financial Group Inc. now owns 12,373,709 shares of the company's stock valued at $374,923,000 after acquiring an additional 134,822 shares in the last quarter. State Street Corp increased its holdings in American Healthcare REIT by 6.5% during the 2nd quarter. State Street Corp now owns 6,902,944 shares of the company's stock valued at $255,289,000 after acquiring an additional 422,931 shares in the last quarter. Invesco Ltd. increased its holdings in American Healthcare REIT by 15.9% during the 2nd quarter. Invesco Ltd. now owns 5,820,530 shares of the company's stock valued at $213,846,000 after acquiring an additional 798,075 shares in the last quarter. Finally, Alliancebernstein L.P. increased its holdings in American Healthcare REIT by 16.7% during the 2nd quarter. Alliancebernstein L.P. now owns 5,318,866 shares of the company's stock valued at $195,415,000 after acquiring an additional 759,501 shares in the last quarter. Institutional investors and hedge funds own 16.68% of the company's stock.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.